Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (331-340 of 365) with videos related to

Pageof 37
Sort By:
Annals of Neurology|January 23, 2014
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageingChristopher C Rowe, Pierrick Bourgeat, Kathryn A Ellis, et al.
Brain : a Journal of Neurology|July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's diseaseGaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2018
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohortsRachel F Buckley, Elizabeth C Mormino, Rebecca E Amariglio, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2012
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's diseaseVictor L Villemagne, William E Klunk, Chester A Mathis, et al.
Neurology|July 26, 2013
Impaired default network functional connectivity in autosomal dominant Alzheimer diseaseJasmeer P Chhatwal, Aaron P Schultz, Keith Johnson, et al.
Pageof 37

Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
Annals of Neurology|January 23, 2014
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageingChristopher C Rowe, Pierrick Bourgeat, Kathryn A Ellis, et al.
Brain : a Journal of Neurology|July 1, 2016
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's diseaseGaël Chételat, Rik Ossenkoppele, Victor L Villemagne, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2018
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohortsRachel F Buckley, Elizabeth C Mormino, Rebecca E Amariglio, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2012
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's diseaseVictor L Villemagne, William E Klunk, Chester A Mathis, et al.
Neurology|July 26, 2013
Impaired default network functional connectivity in autosomal dominant Alzheimer diseaseJasmeer P Chhatwal, Aaron P Schultz, Keith Johnson, et al.
Pageof 37